Zobrazeno 1 - 10
of 154
pro vyhledávání: '"Patrick C, Souverein"'
Autor:
Cindy Sarodnik, Nicklas H. Rasmussen, Sandrine P.G. Bours, Nicolaas C. Schaper, Peter Vestergaard, Patrick C. Souverein, Morten H. Jensen, Johanna H.M. Driessen, Joop P.W. van den Bergh
Publikováno v:
Bone Reports, Vol 17, Iss , Pp 101614- (2022)
Purpose: In this descriptive study, we examined the incidence of fractures in patients with newly treated type 2 diabetes mellitus (T2D) compared to matched reference population. Methods: Participants from the UK Clinical Practice research datalink (
Externí odkaz:
https://doaj.org/article/acad557f81ee460bb9e815604341a07a
Autor:
Talip E. Eroglu, Marieke T. Blom, Patrick C. Souverein, Alfi Yasmina, Anthonius de Boer, Hanno L. Tan, for the ESCAPE-NET investigators
Publikováno v:
PLoS ONE, Vol 17, Iss 6 (2022)
Aim Activated blood platelet products facilitate myocardial intracellular Ca2+ overload, thereby provoking afterdepolarizations and increasing susceptibility of ischemic myocardium to ventricular fibrillation (VF). These effects are counteracted in v
Externí odkaz:
https://doaj.org/article/8d082c23b26641bda0ebb68ad63a608a
Publikováno v:
Pharmacoepidemiology; Volume 1; Issue 2; Pages: 64-75
Depolarization-blocking drugs (DB drugs) used for cardiac disease increase the risk of cardiac arrhythmia (ventricular tachycardia/ventricular fibrillation [VT/VF]) and out-of-hospital cardiac arrest (OHCA) in specific patient groups. However, it is
Autor:
Annelies Boonen, Andrea M. Burden, Tjeerd van Staa, Johanna H M Driessen, Patrick C. Souverein, Shahab Abtahi, Frank de Vries, Joop P. W. van den Bergh
Publikováno v:
Annals of the Rheumatic Diseases, 82(4):e94. BMJ Publishing Group
Response to: 'Correspondence on 'Concomitant use of oral glucocorticoids and proton pump inhibitors and risk of osteoporotic fractures among patients with rheumatoid arthritis: a population-based cohort study'' by Zheng We thank Dr Zheng for his comm
Autor:
Nicholas B. Hunt, Romin Pajouheshnia, Allan Salih, Sander van Doorn, Patrick C. Souverein, Marloes T. Bazelier, Olaf H. Klungel, Helga Gardarsdottir
Publikováno v:
British Journal of Clinical Pharmacology.
Aims: Low-dose rivaroxaban has been indicated for the management of atherosclerotic cardiovascular disease (ASCVD) after recent (2019-2020) updates to European guidelines. We aimed to describe prescription trends of low-dose rivaroxaban in ASCVD pati
Autor:
Marleen E. Jansen, Tessel Rigter, Thom M. C. Fleur, Patrick C. Souverein, W. M. Monique Verschuren, Susanne J. Vijverberg, Jesse J. Swen, Wendy Rodenburg, Martina C. Cornel
Publikováno v:
Genes, 14(2). MDPI
Genes, 14(2):456. Multidisciplinary Digital Publishing Institute (MDPI)
Genes
Volume 14
Issue 2
Pages: 456
Jansen, M E, Rigter, T, Fleur, T M C, Souverein, P C, Verschuren, W M M, Vijverberg, S J, Swen, J J, Rodenburg, W & Cornel, M C 2023, ' Predictive Value of SLCO1B1 c.521T >C Polymorphism on Observed Changes in the Treatment of 1136 Statin-Users ', Genes, vol. 14, no. 2, 456 . https://doi.org/10.3390/genes14020456
Genes, 14(2):456. Multidisciplinary Digital Publishing Institute (MDPI)
Genes
Volume 14
Issue 2
Pages: 456
Jansen, M E, Rigter, T, Fleur, T M C, Souverein, P C, Verschuren, W M M, Vijverberg, S J, Swen, J J, Rodenburg, W & Cornel, M C 2023, ' Predictive Value of SLCO1B1 c.521T >C Polymorphism on Observed Changes in the Treatment of 1136 Statin-Users ', Genes, vol. 14, no. 2, 456 . https://doi.org/10.3390/genes14020456
Pharmacogenomic testing is a method to prevent adverse drug reactions. Pharmacogenomics could be relevant to optimize statin treatment, by identifying patients at high risk for adverse drug reactions. We aim to investigate the clinical validity and u
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::f2d6bc611d6a1592c52faf7c297ae380
http://hdl.handle.net/1887/3594487
http://hdl.handle.net/1887/3594487
Autor:
Anthonius de Boer, Gerard J.J. Boink, Patrick C. Souverein, Lixia Jia, Hanno L. Tan, Arie O. Verkerk, Marieke T. Blom, Harsha D. Devalla, Talip E Eroglu
Publikováno v:
British Journal of Clinical Pharmacology
British Journal of Clinical Pharmacology, 87(9), 3588. NLM (Medline)
British journal of clinical pharmacology, 87(9), 3588-3598. Wiley-Blackwell
British Journal of Clinical Pharmacology, 87(9), 3588-3598. Wiley-Blackwell
Eroglu, T E, Jia, L, Blom, M T, Verkerk, A O, Devalla, H D, Boink, G J J, Souverein, P C, de Boer, A & Tan, H L 2021, ' Sulfonylurea antidiabetics are associated with lower risk of out-of-hospital cardiac arrest : Real-world data from a population-based study ', British Journal of Clinical Pharmacology, vol. 87, no. 9, pp. 3588-3598 . https://doi.org/10.1111/bcp.14774
British Journal of Clinical Pharmacology, 87(9), 3588. NLM (Medline)
British journal of clinical pharmacology, 87(9), 3588-3598. Wiley-Blackwell
British Journal of Clinical Pharmacology, 87(9), 3588-3598. Wiley-Blackwell
Eroglu, T E, Jia, L, Blom, M T, Verkerk, A O, Devalla, H D, Boink, G J J, Souverein, P C, de Boer, A & Tan, H L 2021, ' Sulfonylurea antidiabetics are associated with lower risk of out-of-hospital cardiac arrest : Real-world data from a population-based study ', British Journal of Clinical Pharmacology, vol. 87, no. 9, pp. 3588-3598 . https://doi.org/10.1111/bcp.14774
Aims Out-of-hospital cardiac arrest (OHCA) mostly results from ventricular tachycardia/ventricular fibrillation (VT/VF), often triggered by acute myocardial infarction (AMI). Sulfonylurea (SU) antidiabetics can block myocardial ATP-regulated K+ chann
Autor:
Mads Wissenberg, Patrick C. Souverein, Talip E Eroglu, Hanno L. Tan, C A Barcella, Anthonius de Boer, Christian Torp-Pedersen, Fredrik Folke, Gunnar Gislason, Escape-Net Investigators, Marieke T. Blom, G H Mohr
Publikováno v:
British Journal of Clinical Pharmacology, 88(5), 2256-2266. Wiley-Blackwell
British Journal of Clinical Pharmacology, 88(5), 2256. NLM (Medline)
Eroglu, T E, Barcella, C A, Blom, M T, Souverein, P C, Mohr, G H, Torp-Pedersen, C, Folke, F, Wissenberg, M, de Boer, A, Gislason, G H, Tan, H L & ESCAPE-NET Investigators 2022, ' Opioid use is associated with increased out-of-hospital cardiac arrest risk among 40,000-cases across two countries ', British Journal of Clinical Pharmacology, vol. 88, no. 5, pp. 2256-2266 . https://doi.org/10.1111/bcp.15157
British journal of clinical pharmacology, 88(5), 2256-2266. Wiley-Blackwell
for the ESCAPE-NET investigators 2022, ' Opioid use is associated with increased out-of-hospital cardiac arrest risk among 40 000-cases across two countries ', British Journal of Clinical Pharmacology, vol. 88, no. 5, pp. 2256-2266 . https://doi.org/10.1111/bcp.15157
Eroglu, T E, Barcella, C A, Blom, M T, Souverein, P C, Mohr, G H, Torp-Pedersen, C, Folke, F, Wissenberg, M, de Boer, A, Gislason, G H, Tan, H L & for the ESCAPE-NET Investigators 2022, ' Opioid use is associated with increased out-of-hospital cardiac arrest risk among 40 000-cases across two countries ', British Journal of Clinical Pharmacology, vol. 88, no. 5, pp. 2256-2266 . https://doi.org/10.1111/bcp.15157
British Journal of Clinical Pharmacology, 88(5), 2256. NLM (Medline)
Eroglu, T E, Barcella, C A, Blom, M T, Souverein, P C, Mohr, G H, Torp-Pedersen, C, Folke, F, Wissenberg, M, de Boer, A, Gislason, G H, Tan, H L & ESCAPE-NET Investigators 2022, ' Opioid use is associated with increased out-of-hospital cardiac arrest risk among 40,000-cases across two countries ', British Journal of Clinical Pharmacology, vol. 88, no. 5, pp. 2256-2266 . https://doi.org/10.1111/bcp.15157
British journal of clinical pharmacology, 88(5), 2256-2266. Wiley-Blackwell
for the ESCAPE-NET investigators 2022, ' Opioid use is associated with increased out-of-hospital cardiac arrest risk among 40 000-cases across two countries ', British Journal of Clinical Pharmacology, vol. 88, no. 5, pp. 2256-2266 . https://doi.org/10.1111/bcp.15157
Eroglu, T E, Barcella, C A, Blom, M T, Souverein, P C, Mohr, G H, Torp-Pedersen, C, Folke, F, Wissenberg, M, de Boer, A, Gislason, G H, Tan, H L & for the ESCAPE-NET Investigators 2022, ' Opioid use is associated with increased out-of-hospital cardiac arrest risk among 40 000-cases across two countries ', British Journal of Clinical Pharmacology, vol. 88, no. 5, pp. 2256-2266 . https://doi.org/10.1111/bcp.15157
Aims Opioid use has substantially increased in the last decade and is associated with overdose mortality, but also with increased mortality from cardiovascular causes. This finding may partly reflect an association between opioids and out-of-hospital
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::048f17852929452cf6aa838f9bb33575
https://research.vumc.nl/en/publications/551c386a-9249-4f68-bbb6-a50df0c392b5
https://research.vumc.nl/en/publications/551c386a-9249-4f68-bbb6-a50df0c392b5
Autor:
Cornelis A van den Bogert, Patrick C Souverein, Cecile T M Brekelmans, Susan W J Janssen, Gerard H Koëter, Hubert G M Leufkens, Lex M Bouter
Publikováno v:
PLoS ONE, Vol 11, Iss 12, p e0167709 (2016)
The objective of this study was to investigate the occurrence and determinants of non-publication of clinical drug trials in the Netherlands.All clinical drug trials reviewed by the 28 Institutional Review Boards (IRBs) in the Netherlands in 2007 wer
Externí odkaz:
https://doaj.org/article/c3f181797aa2418dbc42edeef9e74b5c
Autor:
Patrick C. Souverein, Hanno L. Tan, David D Salcido, Rudolph W. Koster, Michiel Hulleman, Marieke T. Blom, James J. Menegazzi
Publikováno v:
Resuscitation, 151, 173-180. Elsevier Ireland Ltd
Resuscitation
Resuscitation, 151, 173. Elsevier Ireland Ltd.
Hulleman, M, Salcido, D D, Menegazzi, J J, Souverein, P C, Tan, H L, Blom, M T & Koster, R W 2020, ' Ventricular fibrillation waveform characteristics in out-of-hospital cardiac arrest and cardiovascular medication use ', Resuscitation, vol. 151, pp. 173-180 . https://doi.org/10.1016/j.resuscitation.2020.02.027
Resuscitation
Resuscitation, 151, 173. Elsevier Ireland Ltd.
Hulleman, M, Salcido, D D, Menegazzi, J J, Souverein, P C, Tan, H L, Blom, M T & Koster, R W 2020, ' Ventricular fibrillation waveform characteristics in out-of-hospital cardiac arrest and cardiovascular medication use ', Resuscitation, vol. 151, pp. 173-180 . https://doi.org/10.1016/j.resuscitation.2020.02.027
Background: Ventricular fibrillation (VF) waveform analyses are considered a reliable proxy for OHCA characteristics in out-of-hospital cardiac arrest (OHCA), but patient characteristics such as cardiovascular medication use might also be associated